Bill Woywod

Creating a digital diagnostic that is supplemental and strategic to a company’s therapeutic asset requires due diligence to monetize the digital health innovation, or at least ensure optionality through the product development cycle.

How machine learning can provide an on-demand portfolio-wide view of optimal provider targeting and related field deployment.